SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001083
Filing Date
2021-08-09
Accepted
2021-08-09 16:28:46
Documents
67
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cyt-20210630.htm   iXBRL 10-Q 1684058
2 EX-31.1 cyt-20210630ex31_1.htm EX-31.1 16414
3 EX-31.2 cyt-20210630ex31_2.htm EX-31.2 16390
4 EX-32.1 cyt-20210630ex32_1.htm EX-32.1 9693
5 EX-32.2 cyt-20210630ex32_2.htm EX-32.2 9679
  Complete submission text file 0000950170-21-001083.txt   5739454

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cyt-20210630_pre.xml EX-101.PRE 250501
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cyt-20210630_lab.xml EX-101.LAB 334459
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cyt-20210630.xsd EX-101.SCH 42366
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cyt-20210630_cal.xml EX-101.CAL 30276
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cyt-20210630_def.xml EX-101.DEF 148486
11 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20210630_htm.xml XML 889537
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40499 | Film No.: 211156907
SIC: 2834 Pharmaceutical Preparations